- Advances in the treatment of acute lymphoblastic leukemia in children2020 | Second Faculty of Medicine
- Fifty years of successful treatment of childhood acute lymphoblastic leukemia2007 | Second Faculty of Medicine
- Childhood Acute Lymphoblastic Leukemia: Results of the Randomized Acute Lymphoblastic Leukemia Intercontinental-Berlin-Frankfurt-Münster 2009 Trial2023 | Second Faculty of Medicine
- Near-tetraploid childhood acute lymphoblastic leukemias: EGIL study of 20 casesPublication without faculty affiliation
- Optimizing asparaginase therapy for acute lymphoblastic leukemia2013 | Second Faculty of Medicine
- Posttreatment positivity of BCR::ABL1 in acute lymphoblastic leukemia: Should we keep track?2023 | Second Faculty of Medicine
- New therapeutic modalities in the treatment of childhood acute lymphoblastic leukemia2022 | Second Faculty of Medicine
- The importance of blast cell DNA content for prognosis of childhood acute lymphoblastic leukemia1990 | Second Faculty of Medicine
- Ten-year experience with therapy of relapsing acute lymphoblastic leukemia in childhood1997 | Second Faculty of Medicine
- CD371 cell surface expression: A unique feature of DUX4-rearranged acute lymphoblastic leukemia2019 | Second Faculty of Medicine
- Role of cytogenetic analysis in current management of childhood acute lymphoblastic leukemia treatment2015 | Faculty of Medicine in Pilsen
- TEL deletion analysis supports a novel view of relapse in childhood acute lymphoblastic leukemia2004 | Second Faculty of Medicine
- Statement by members of the Ponte di Legno group on the right of children with leukemia to have full access to essential treatment for acute lymphoblastic leukemia2005 | Second Faculty of Medicine
- The controversy of varicella vaccination in children with acute lymphoblastic leukemia2012 | Second Faculty of Medicine
- Expression pattern of homeodomain genes does not define the known subgroups of childhood acute lymphoblastic leukemias2010 | Second Faculty of Medicine, Faculty of Science
- PTEN/PI3K/Akt pathway alters sensitivity of T-cell acute lymphoblastic leukemia to L-asparaginase2022 | Second Faculty of Medicine
- Transfer of genomics information to flow cytometry: expression of CD27 and CD44 discriminates subtypes of acute lymphoblastic leukemia2005 | Faculty of Mathematics and Physics
- Methods of Dendritic Cell Preparation for Acute Lymphoblastic Leukemia Immunotherapy in Children2005 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Physical Education and Sport
- Favorable outcome of NUTM1-rearranged infant and pediatric B cell precursor acute lymphoblastic leukemia in a collaborative international study2021 | Second Faculty of Medicine
- Importance of using comparative genomic hybridization to improve detection of chromosomal changes in childhood acute lymphoblastic leukemia2000 | Second Faculty of Medicine
- Third consecutive national study ALL-BFM 95 improved the outcome of acute lymphoblastic leukemia in children in the Czech Republic2008 | First Faculty of Medicine
- Definition and Prognostic Value of Ph-like and IKZF1plus Status in Children With Down Syndrome and B-cell Precursor Acute Lymphoblastic Leukemia2023 | Second Faculty of Medicine
- Treatment of disseminated zygomycosis in an infant with acute lymphoblastic leukemia with amphotericin B lipid complex2011 | Second Faculty of Medicine
- A Phase I study of inotuzumab ozogamicin in pediatric relapsed/refractory acute lymphoblastic leukemia (ITCC-059 study)2021 | Second Faculty of Medicine
- Assessment of extramedullary leukemic infiltration in childhood acute lymphoblastic leukemia and its clinical use. Review and original data2012 | Second Faculty of Medicine
- Plethysmographic and Biochemical Markers in the Diagnosis of Endothelial Dysfunction in Pediatric Acute Lymphoblastic Leukemia Survivors - New Applications2018 | Faculty of Medicine in Pilsen
- Proteomic analysis of soluble proteins important in pediatric acute lymphoblastic leukemia2010 | Second Faculty of Medicine
- Genomic landscape of B-other acute lymphoblastic leukemia in an adult retrospective cohort with a focus on BCR-ABL1-like subtype2021 | First Faculty of Medicine
- Eligibility for allogeneic transplantation in very high risk childhood acute lymphoblastic leukemia: the impact of the waiting time2008 | Second Faculty of Medicine
- CD38: A target in relapsed/refractory acute lymphoblastic leukemia-Limitations in treatment and diagnostics2022 | Second Faculty of Medicine